Controversy and consensus on the management of patients with pseudomyxoma peritonei

Current Treatment Options in Oncology

Volumn 14, Issue 3, 2013, Pages 365-373

  Faris, Jason E ^a   Ryan, David P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Carcinomatosis; Cytoreduction; Heated intraperitoneal chemotherapy; Pseudomyxoma peritonei

Indexed keywords

FLUOROURACIL; MITOMYCIN; MUCIN;

ABDOMINAL SCINTISCANNING; APPENDICITIS; APPENDIX TUMOR; ARTICLE; CANCER PROGNOSIS; CARCINOMATOUS PERITONITIS; CHEMOTHERAPY; CLINICAL FEATURE; CONSENSUS; CYTOREDUCTIVE SURGERY; HEATED INTRAPERITONEAL CHEMOTHERAPY; HISTOPATHOLOGY; HUMAN; META ANALYSIS (TOPIC); MORTALITY; OVERALL SURVIVAL; PATIENT CARE; PERITONEUM PSEUDOMYXOMA; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUMOR CLASSIFICATION;

CARCINOMA; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MITOMYCIN; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI;

EID: 84884207241     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-013-0240-x     Document Type: Article

References (38)

1. Werth R. Klinische und anatomische untersuchungen zur lehre von den bauchgeschwullsten und der laparotomie. Arch Gynecol. 1884;24:100-18.
2. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245(1):104-9. Epub 2007/01/02.
3. Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2008;34(2):196-201. Epub 2007/05/26.
4. McDonald JR, O'Dwyer ST, Rout S, Chakrabarty B, Sikand K, Fulford PE, et al. Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms. Br J Surg. 2012;99(7):987-92. Epub 2012/04/21.
5. Mann Jr WJ, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer. 1990;66(7):1636-40. Epub 1990/10/01.
6. Misdraji J. Appendiceal mucinous neoplasms: controversial issues. Arch Pathol Lab Med. 2010;134(6):864-70. Epub 2010/06/09.
7. Nakakura EK. Pseudomyxoma peritonei: more questions than answers. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(20):2429-30. Epub 2012/05/23.
8. Panarelli NC, Yantiss RK. Mucinous neoplasms of the appendix and peritoneum. Arch Pathol Lab Med. 2011;135(10):1261-8. Epub 2011/10/06.
9. Carr NJ, Finch J, Ilesley IC, Chandrakumaran K, Mohamed F, Mirnezami A, et al. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol. 2012;65(10):919-23. Epub 2012/06/22. Experience of 274 patients PMP categorized as low or high grade, with significant impact on prognosis.
10. Misdraji J, Yantiss RK, Graeme-Cook FM, Balis UJ, Young RH. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003;27(8):1089-103. Epub 2003/07/29.
11. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to «pseudomyxoma peritonei». Am J Surg Pathol. 1995;19(12):1390-408.
12. Bradley RF, Stewart IV JH, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30(5):551-9. Epub 2006/05/16.
13. Carr NJ, McCarthy WF, Sobin LH. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer. 1995;75(3):757-68.
14. Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification. Adv Anat Pathol. 2005;12(6):291-311. Epub 2005/12/07.
15. Carr NJSL. Adenocarcinoma of the appendix. In: Bosman FTCF, Hruban RH, editors. WHO Classification of Tumors of the Digestive System. Lyon: IARC; 2010.
16. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92(1):85-91. Epub 2001/07/10.
17. Guo AT, Li YM, Wei LX. Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors. World J Gastroenterol. 2012;18(24):3081-8. Epub 2012/07/14.
18. Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2012;30(20):2449-56. Epub 2012/05/23. Largest retrospective experience with PMP and CRS/HIPEC detailing long-term survival.
19. Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? The lancet oncology. 2012;13(8):e362-9. Epub 2012/08/01. This paper addresses the controversies surrounding cytoreductive surgery and HIPEC in the management of peritoneal carcinomatosis.
20. Esquivel J, Sugarbaker PH. Clinical presentation of the Pseudomyxoma peritonei syndrome. Br J Surg. 2000;87(10):1414-8. Epub 2000/10/24.
21. Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg. 1994;219(2):112-9. Epub 1994/02/01.
22. Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241(2):300-8. Epub 2005/01/15.
23. Sugarbaker PH. Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Can J Surg. 1989;32(3):164-70. Epub 1989/05/01.
24. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6(8):727-31. Epub 2000/01/06.
25. McBride K, McFadden D, Osler T. Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis. J Surg Res. 2013. Epub 2013/03/16. Meta-analysis of 15 studies analyzing survival associated with combined cytoreductive surgery and intraperitoneal chemotherapy.
26. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98(4):277-82. Epub 2008/08/30.
27. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 2006;7(1):69-76. Epub 2006/01/04.
28. Canbay E, Ishibashi H, Sako S, Mizumoto A, Hirano M, Ichinose M, et al. Preoperative Carcinoembryonic Antigen Level Predicts Prognosis in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. World J Surg. 2013. Epub 2013/03/08.
29. Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, et al. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2007;14(8):2300-8. Epub 2007/05/19.
30. Shetty S, Thomas P, Ramanan B, Sharma P, Govindarajan V, Loggie B. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis. J Surg Res. 2013;180(1):97-103. Epub 2012/12/04.
31. Andreasson H, Wanders A, Sun XF, Willen R, Graf W, Nygren P, et al. Histopathological classification of pseudomyxoma peritonei and the prognostic importance of PINCH protein. Anticancer Res. 2012;32(4):1443-8. Epub 2012/04/12.
32. Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2012;30(3):263-7. Epub 2011/12/14. Outcomes of patients with peritoneal carcinomatosis of colorectal origin from two randomized trials, demonstrating inferior outcomes relative to metastatic colorectal cancer without peritoneal carcinomatosis.
33. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(24):4011-9. Epub 2006/08/22.
34. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(20):3737-43. Epub 2003/10/11.
35. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426-32. Epub 2008/06/04.
36. Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116(24):5608-18. Epub 2010/08/26.
37. Elias D, Delperro JR, Sideris L, Benhamou E, Pocard M, Baton O, et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol. 2004;11(5):518-21. Epub 2004/05/05.
38. National Comprehensive Cancer Network. NCCN Guidelines Colon Cancer, Version 3.2013.